Dinesh V Ph D Patel sold $18.2M of Protagonist Therapeutics (PTGX)

Executed Sep 8, disclosed Sep 11, 2 days later.

Value, as filed

$18.2M

125,000 sh across 3 lots

Executed

Sep 8

the trade date, as filed

Disclosed

Sep 11

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Dinesh V Ph D Patel President and CEO profile →

Dinesh V Ph D Patel (President and CEO) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Protagonist Therapeutics, Inc. (PTGX). The largest single filing was $18.2M of PTGX (125,000 sh across 3 lots, as filed), executed Sep 8.

The name

PTGX

Protagonist Therapeutics, Inc. PTGX · Healthcare · 36 filings in 24 months ticker →

Healthcare · Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Dinesh V Ph D Patel in PTGX

PTGXSALE Protagonist Therapeutics, Inc. $14.9M
100,000 sh across 2 lots
Exec Aug 10
Filed Aug 12 · 6:43 PM ET PTGXSALE Protagonist Therapeutics, Inc. $7.5M
75,000 sh × $100.12
Exec May 12
Filed May 12 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. $7.5M
75,000 sh × $100.12
Exec May 12
Filed May 14 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. $5.5M
54,641 sh × $101.00
Exec Mar 25
Filed Mar 25 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. $4.1M
48,273 sh across 4 lots
Exec Jan 23
Filed Jan 27 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. $2.8M
34,438 sh × $82.48
Exec Jan 20
Filed Jan 21 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. $571K
10,415 sh × $54.78
Exec Jul 25 2025
Filed Jul 28 2025 · 5:30 PM ET PTGXSALE Protagonist Therapeutics, Inc. $2.9M
52,444 sh across 3 lots
Exec Jul 21 2025
Filed Jul 23 2025 · 5:30 PM ET